Zhefeng Liu

机构：Chinese PLA General Hospital, PLA Academy of Military Science · ORCID：0000-0002-6160-7194

发表论文 60 篇 · 总被引 1069 次 · h-index 18

代表论文

• Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors (2023 · Thoracic Cancer · 被引 29)
• Mechanism of action and future perspectives of ADCs in combination with immune checkpoint inhibitors for solid tumors (2025 · Clinical and Experimental Medicine · 被引 23)
• Host defense peptide-mimicking peptide polymer-based antibacterial hydrogel enables efficient healing of MRSA-infected wounds (2023 · Science China Chemistry · 被引 22)
• Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review (2024 · Frontiers in Neurology · 被引 21)
• Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer (2024 · Thoracic Cancer · 被引 19)
• Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors (2024 · Global Medical Genetics · 被引 15)